- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction in Poland
Total 157 results
-
Medical University of LublinUnknownAdenocarcinoma of the Gastroesophageal JunctionPoland
-
NRG OncologyNational Cancer Institute (NCI)RecruitingClinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Unresectable Gastroesophageal Junction Adenocarcinoma | Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma... and other conditionsUnited States
-
Gulam ManjiMerck Sharp & Dohme LLCCompletedGastric Cancer | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingClinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IV Gastric Cancer AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction... and other conditionsUnited States, Puerto Rico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedGastric Cancer | Gastric Adenocarcinoma | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
National Cancer Institute (NCI)SuspendedEsophageal Adenocarcinoma | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Gastroesophageal Junction Adenocarcinoma | Clinical Stage II Esophageal Adenocarcinoma AJCC v8 | Clinical Stage III Esophageal Adenocarcinoma AJCC v8 | Clinical Stage IVA Esophageal Adenocarcinoma... and other conditionsUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); AmgenCompletedEsophageal Cancer | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
National Cancer Institute (NCI)RecruitingGastric Adenocarcinoma | Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Gastroesophageal Junction Adenocarcinoma | Clinical Stage I Gastric Cancer AJCC v8 | Clinical Stage II Gastric Cancer AJCC v8 | Clinical Stage IVA Gastric... and other conditionsUnited States
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
-
Foundation for Liver ResearchWithdrawnAdenocarcinoma of the Pancreas | Normal Pancreatic Exocrine FunctionNetherlands
-
NRG OncologyNational Cancer Institute (NCI)RecruitingClinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8 | Postneoadjuvant Therapy Stage IIIB Gastroesophageal... and other conditionsUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedUnresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal JunctionUnited States, Spain, Italy, Australia, Russian Federation, Taiwan, Korea, Republic of, Thailand, Canada, Turkey, Germany, Romania, United Kingdom, Hungary, Brazil, France, Japan
-
Bristol-Myers SquibbCompletedLocally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal JunctionFrance, Poland, Russian Federation, Taiwan, United States, Hong Kong, Spain, Germany, Italy, Japan, Korea, Republic of, Singapore
-
MedImmune LLCCompletedGastric or Gastroesophageal Junction AdenocarcinomaCanada, United States, Taiwan, Korea, Republic of, Japan, Singapore
-
National Cancer Institute (NCI)CompletedRecurrent Gastric Carcinoma | Adenocarcinoma of the Gastroesophageal Junction | Diffuse Gastric Adenocarcinoma | Gastric Intestinal Type Adenocarcinoma | Gastric Mixed AdenocarcinomaUnited States, Canada
-
BeiGeneActive, not recruitingGastric, or Gastroesophageal Junction AdenocarcinomaUnited States, China, Spain, Korea, Republic of, Poland, Russian Federation, Taiwan, France, Turkey, Japan, Italy, United Kingdom, Puerto Rico
-
Bavarian NordicActive, not recruitingChordoma | HER2-positive Breast Cancer | HER2-positive Gastric/Gastroesophageal Junction CancerUnited States
-
Artiva Biotherapeutics, Inc.Not yet recruitingBreast Cancer | Gastric Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of, United States
-
Medical University of LublinSt Johns' Oncology Center in LublinUnknownAdenocarcinoma of the Esophago-gastric JunctionPoland
-
Jagiellonian UniversityUnknown
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedGastric Cancer | Esophageal Cancer | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingGastric Cancer | Esophageal Adenocarcinoma | Gastroesophageal Junction CancerUnited States, Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Czechia, France, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Portugal, Romania, Russian Federation, Si... and more
-
Kantonsspital LiestalCompletedBenign or Early Malignant Lesion of the Distal Esophagus or Gastro-esophageal Junction Requiring Surgical ResectionSwitzerland
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedUnresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | Gastric Cancer Third LineSpain, Italy, Australia, Korea, Republic of, Belgium, France, Poland, United States, Czechia, Germany
-
Legend Biotech USA IncRecruitingGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Gastroesophageal-junction CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Esophageal Carcinoma | Recurrent Gastric Carcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | Unresectable Gastroesophageal Junction Adenocarcinoma | Metastatic Esophageal Carcinoma | Metastatic Gastric Carcinoma | Stage IV Esophageal Cancer AJCC v7 | Stage IV Gastric Cancer... and other conditionsUnited States
-
Eli Lilly and CompanyCompletedGastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaUnited States, Poland, Romania, Hungary, Russian Federation, Australia, France, Argentina, United Kingdom, New Zealand, Turkey, Slovakia
-
Brown UniversityAstraZenecaRecruitingEsophageal Cancer | Esophageal Adenocarcinoma | HER-2 Protein Overexpression | Gastroesophageal-junction CancerUnited States
-
MorphotekCompletedAdenocarcinoma of the LungSpain, United States, Australia, Canada, Germany, Italy, Poland, Russian Federation
-
UbiVacProvidence Health & Services; Providence Cancer Center, Earle A. Chiles Research... and other collaboratorsCompletedAdenocarcinoma of the ProstateUnited States
-
MacroGenicsZai Lab (Shanghai) Co., Ltd.Active, not recruitingGastric Cancer | Gastroesophageal Junction Cancer | HER2-positive Gastric CancerKorea, Republic of, United States, China, Italy, Taiwan, Germany, Singapore, United Kingdom, Poland
-
Gilead SciencesCompletedGastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaSpain, United States, Hungary, United Kingdom, Italy, France, Poland, Australia, Belgium
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; Stand Up To Cancer; Aduro Biotech, Inc.; American Association... and other collaboratorsCompletedPreviously Treated Metastatic Adenocarcinoma of the PancreasUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingGastric Cancer | Gastroesophageal Junction CancerUnited States, Belgium, Brazil, Canada, Chile, China, Estonia, France, Germany, Guatemala, Israel, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Malaysia, Philippines, Poland, Russian Federation, Singapore, Taiwan, Ukraine, United...
-
NRG OncologyNational Cancer Institute (NCI)RecruitingAdenocarcinoma of the Rectum | Adenocarcinoma of the ColonUnited States
-
Eli Lilly and CompanyCompletedMetastatic Gastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaGermany, Italy, Spain, United States, Hungary, Russian Federation, Poland, Belgium, Netherlands, France, Czechia, Mexico, Argentina, Canada, Denmark, Finland, Israel, Japan, Puerto Rico, United Kingdom
-
AstraZenecaRecruitingGastric Cancer | Pancreatic Adenocarcinoma | Gastroesophageal Junction CancerUnited States, Spain, United Kingdom, Korea, Republic of, Japan, Taiwan, Malaysia, Canada, Singapore, Moldova, Republic of, Australia, Georgia
-
Jagiellonian UniversityRecruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Sky FoundationActive, not recruitingPancreatic Adenocarcinoma | Borderline Resectable Adenocarcinoma of the Head of the PancreaseUnited States, Canada
-
Gulam ManjiRegeneron Pharmaceuticals; BioLine RxRecruitingAdenocarcinoma | Pancreatic Cancer | Adenocarcinoma of the PancreasUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors | Adenocarcinoma of the ProstateUnited States
-
Axelar ABCompletedNon-small-cell Lung Cancer | Squamous Cell Carcinoma | Adenocarcinoma of the LungRussian Federation, Ukraine, Belarus, Hungary, Poland
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedAdvanced Colorectal Cancer | Adenocarcinoma of the Rectum | Adenocarcinoma of the ColonUnited States, Australia, Belgium, Brazil, Canada, Czech Republic, Greece, Korea, Republic of, New Zealand, Poland, Portugal, Romania, Russian Federation, Spain
-
AstraZenecaRecruitingGastric Cancer | Gastroesophageal Junction CancerCanada, Spain, United Kingdom, China, France, Italy, Vietnam, Germany, United States, India, Taiwan, Thailand, Hong Kong, Japan, Switzerland, Poland
-
Eli Lilly and CompanyAstraZenecaCompletedHepatocellular Carcinoma | Gastric Cancer | Non-Small Cell Lung Cancer | Gastroesophageal Junction AdenocarcinomaUnited States, Spain, Korea, Republic of, Taiwan, Germany, Italy, France, Israel
-
AmgenRecruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of, United States, Israel, Italy, Spain, Switzerland, Canada, Australia, Germany, United Kingdom, Austria, France, Japan, Taiwan, China, Belgium, Poland, Thailand, Czechia, Singapore, Hungary, Argentina, Brazil, Romania, Portuga... and more
-
Daiichi SankyoAstraZenecaRecruitingGastroesophageal Junction Adenocarcinoma | Gastric Cancer, AdenocarcinomaHong Kong, Korea, Republic of, France, United Kingdom, Spain, China, Ireland, Brazil, Japan, Singapore, Belgium, Israel, Russian Federation, Argentina, Chile, Hungary, Poland, Portugal, Taiwan, Turkey, Ukraine, Germany, Romania, Italy
-
OHSU Knight Cancer InstitutePfizerTerminatedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
AmgenZai Lab (China only)RecruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaCanada, Japan, United States, Korea, Republic of, China, Italy, Australia, Sweden, Spain, Taiwan, France, Belgium, Denmark, Thailand, Turkey, Czechia, Bulgaria, Brazil, Norway, Mexico, Poland, Estonia, Israel, Greece, Romania, Chile, Peru, Po... and more
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Astellas Pharma Inc; Medivation, Inc.Active, not recruitingAdenocarcinoma of the ProstateUnited States